NOTCH2 and small cell lung carcinoma: In small-cell lung cancer (SCLC), the prevalence of loss-of-function mutations of Notch proteins is reported to be about 25–28%, with Notch1 being the most frequently mutated, followed by Notch2, Notch4, and Notch3 [32].